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Abstract
In recent years, regenerative medicine using cells for treating tissue defects has
been in the spotlight as a new treatment for severe heart failure. Direct injection of
bone marrow-derived cells and isolated skeletal myoblasts has already been used
clinically as a method to improve cardiac function by regenerating cardiac muscle
cells andbloodvessels. The research on reconstructing functional three-dimensional
(3D) cardiac grafts using tissue engineeringmethods has also nowbeen addressed as
a treatment for the next generation. Our laboratory has proposed an original tissue
engineering technology called “cell sheet engineering” that stacks cell sheets to
reconstruct functional 3D tissues. Transplantation of cell sheets has already shown it
can cure damaged hearts, and it seems clear that the field of cell sheet tissue
engineering can offer realistic treatment for patients with severe cardiac disorders.
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3.1 Introduction
Heart transplantation is the last hope for treatment of patients with severe heart failure
due to ischemia-related disease and dilated cardiomyopathy. However, the lack of
donor organs for transplantation continues to be a serious problem around the world.
Although there have been many developments in artificial heart systems such as
mechanical temporary assist devices or left ventricular assist devices (LVADs),
there are also problems in conjunction with thromboembolism, infection, and finite
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durability. Given these challenges with current technologies, regenerative therapies
are being investigated as an alternative approach and present new possibilities for the
repair of a damaged heart. Recently, the direct injection of either autologous skeletal
myoblasts or bone marrow-derived cells has been examined in clinical studies as an
alternative cell source to cardiac muscle cells [1–3]. The direct injection of the
dissociated cells has shown to be slightly effective, but it is often difficult to control
the form, dimensions, or the position of implanted cells. In an attempt to solve these
problems, research on advanced therapies using functional tissue produced by
engineered cardiac grafts has started. Over the past decade, several studies have proved
that bioengineered cardiac tissues could improve cardiac function in animal models of
impaired heart [4]. In this review, we discuss the progress of research on myocardial
regeneration with a focus on our own original approach using cell sheet engineering.
3.2 Cell Sheet Engineering
We have developed our own “cell sheet engineering” method using temperature-
responsive culture dishes created by the covalent grafting of a temperature-responsive
polymer, poly(N-isopropylacrylamide) (PIPAAm), to normal cell culture dishes
[5]. Under normal culture conditions at 37 C, the dish surface is relatively hydropho-
bic, and cells can attach, spread, and proliferate similar to commercially available
tissue culture surfaces. However, when the temperature is reduced to below the
polymer’s lower critical solution temperature of 32 C, the polymer surface becomes
hydrophilic and swells, forming a hydration layer between the dish surface and the
cultured cells. This allows the cells to detach as a single sheet without the need of
enzymatic treatments such as trypsinization. Since the use of proteolysis measures is
unnecessary, critical cell surface proteins and cell-to-cell junction proteins remain
intact, so that the cells can be harvested noninvasively as an intact sheet while
retaining their extracellular matrix (ECM) (Fig. 3.1). Consequently, we can recreate
3D structures such as cardiac tissue by repeated layering of individual cell sheets [6].
3.3 Cardiac Tissue Reconstruction
Harvested cell sheets consist of only confluently cultured cells with their biological
ECMon the basal side of the cell sheets, which acts as an adhesive agent for promoting
an intimate attachment between each layered cardiac cell sheet.Within layered cardiac
constructs, gap junctions are formed which rapidly establish an electrical connection
between the cell sheets, leading to 3D cardiac tissues that synchronously pulsatile
[7]. Additionally, when these tissueswere transplanted onto the subcutaneous tissue of
nude rats, the grafts were macroscopically observed to beat synchronously [8]. Impor-
tantly, these implanted tissues also showed long-term survival up to 1 year and
8 months, and the grafts also contained elongated sarcomeres, gap junctions, and
well-organized vascular networks within the bioengineered cardiac tissues [9].
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3.4 Cell Sheet Transplantation in Small Animal Models
Transplantation of engineered tissue such as cardiac grafts onto infarcted rat hearts
(Fig. 3.2) demonstrated morphological and functional connections via bridging
cardiomyocytes that migrated from the transplanted grafts to the host heart
[10]. Cardiac graft transplantation also improved damaged heart function with
significant improvements in the host ejection fraction [11]. We have also
demonstrated that control of EC densities in engineered cardiac tissues induces
enhanced neovascularization and leads directly to improved function of the ische-
mic myocardium [12]. Moreover, when compared to direct cell injection, the
cardiac graft transplantation exhibited superior cell survival and engraftment
[13]. Similarly, skeletal myoblast grafts were able to improve left ventricular
contraction, reduce fibrosis, and prevent remodeling via the recruitment of
hematopoietic stem cells through the release of various growth factors [14]. The
implantation of myoblast grafts also induced the restoration of left ventricular
dilatation and prolonged life expectancy in dilated cardiomyopathic hamster
[15]. Additionally, mesenchymal stem cell grafts demonstrated improved cardiac
function in impaired rat hearts, with the reversal of cardiac wall thinning and
prolonged survival after myocardial infarction. This recovery after myocardial
infarction suggests that the improvement in cardiac function may be primarily
due to the effects of growth factor-mediated paracrine and/or a decrease in left
ventricle wall stress, which in turn result from the relatively thick mesenchymal
stem cell sheets [16].
Fig. 3.1 Cell sheet engineering. Using temperature-responsive dishes, cultured cells can be
harvested as intact contiguous sheets by simple temperature reduction without proteolytic
treatment
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3.5 Cell Sheet Transplantation in Preclinical and Clinical
Studies
Our latest work has been to transplant engineered tissue in clinically relevant large-
animal models. In a pacing-induced canine dilated cardiomyopathy model, trans-
plantation of skeletal myoblast grafts has shown improved cardiac function with
reduction of fibrosis and apoptosis [17]. In a porcine cardiac infarction model,
skeletal myoblast graft transplantation provided improvement of cardiac function
with attenuation of cardiac remodeling [18]. Transplantation of skeletal myoblast
grafts has also demonstrated that it is an appropriate and safe treatment for chronic
myocardial infarction without increasing the risk of ventricular arrhythmias. Most
recently, the transplantation of cardiac progenitor cell grafts derived from embry-
onic stem cells improved cardiac function without teratoma formation and induced
cardiomyogenic differentiation in a simian impaired heart model. Our latest work
provides evidence of the safety and efficacy of using embryonic stem cells for
myocardial regeneration [19].
Based on the promising results in various animal models, there is a clinical study
using cell sheet transplantation currently underway. Autologous skeletal myoblast
sheet therapy has demonstrated that it is possible to improve cardiac function to
such a degree that LVADs are no longer required for patients with dilated
cardiomyopathy [20].
Fig. 3.2 Transplantation of the cardiac grafts onto infarcted rat hearts
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3.6 Conclusions
The field of tissue engineering presents an exciting approach to regenerative
therapies. The future solutions scaling up give more powerful construct creation,
resulting in the developments of remarkable tissue-engineered cardiac assist
devices or organ replacement. Overall, cell sheet tissue engineering is a novel
approach for cardiac treatment that promises efficient and effective alternative
therapies in regenerative medicine.
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